Ricardo Marius
Publications by Year
Research Areas
Virus-based gene therapy research, CAR-T cell therapy research, Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents(2003)842 cited
- → Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus(2000)813 cited
- → The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus(2000)194 cited
- → In Vivo Regulation of Alternative Pre-mRNA Splicing by the Clk1 Protein Kinase(1997)192 cited
- → The Clk2 and Clk3 Dual-Specificity Protein Kinases Regulate the Intranuclear Distribution of SR Proteins and Influence Pre-mRNA Splicing(1998)139 cited
- → Alternative Splicing of STY, a Nuclear Dual Specificity Kinase(1995)75 cited
- → Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies(2023)30 cited
- → Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer(2022)29 cited
- → Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection(2021)23 cited
- → Cell adhesion properties of myelin‐associated glycoprotein in L cell fibroblasts(1991)18 cited